Voyager Therapeutics
Benjamin Smith is a highly experienced professional in the field of protein sciences and bioconjugation, currently serving as Senior Director at Voyager Therapeutics, Inc., focusing on non-viral therapeutics since April 2025. Prior to this role, Benjamin contributed significantly to Biogen over a twelve-year span, progressing from Scientist I to Associate Scientific Director, primarily in biologics drug discovery and tissue enhanced delivery. Benjamin's earlier experience includes postdoctoral fellowships at Brandeis University and The University of British Columbia, where research concentrated on single molecule analysis and the mechanics of lipid membranes, respectively. Benjamin's academic foundation includes a PhD in Biophysics and a BSc in Physics from McGill University, emphasizing expertise in biophysical techniques and cellular mechanics.
This person is not in any teams
This person is not in any offices
Voyager Therapeutics
1 followers
Voyager Therapeutics is a clinical-stage gene therapy company focused on developing life-changing treatments for severe neurological diseases.